GB0702930D0 - Medicaments and methods for inhibition of scarring - Google Patents

Medicaments and methods for inhibition of scarring

Info

Publication number
GB0702930D0
GB0702930D0 GBGB0702930.9A GB0702930A GB0702930D0 GB 0702930 D0 GB0702930 D0 GB 0702930D0 GB 0702930 A GB0702930 A GB 0702930A GB 0702930 D0 GB0702930 D0 GB 0702930D0
Authority
GB
United Kingdom
Prior art keywords
scarring
medicaments
inhibition
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0702930.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0702930.9A priority Critical patent/GB0702930D0/en
Publication of GB0702930D0 publication Critical patent/GB0702930D0/en
Priority to CA002678389A priority patent/CA2678389A1/en
Priority to JP2009549467A priority patent/JP2010519192A/ja
Priority to AU2008216004A priority patent/AU2008216004A1/en
Priority to EP08709394A priority patent/EP2117581A1/en
Priority to PCT/GB2008/000500 priority patent/WO2008099174A1/en
Priority to US12/527,182 priority patent/US20110212897A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0702930.9A 2007-02-15 2007-02-15 Medicaments and methods for inhibition of scarring Ceased GB0702930D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0702930.9A GB0702930D0 (en) 2007-02-15 2007-02-15 Medicaments and methods for inhibition of scarring
CA002678389A CA2678389A1 (en) 2007-02-15 2008-02-14 Wnt3a for inhibition of scarring
JP2009549467A JP2010519192A (ja) 2007-02-15 2008-02-14 瘢痕の抑制のためのｗｎｔ３ａ
AU2008216004A AU2008216004A1 (en) 2007-02-15 2008-02-14 WNT3A for inhibition of scarring
EP08709394A EP2117581A1 (en) 2007-02-15 2008-02-14 Wnt3a for inhibition of scarring
PCT/GB2008/000500 WO2008099174A1 (en) 2007-02-15 2008-02-14 Wnt3a for inhibition of scarring
US12/527,182 US20110212897A1 (en) 2007-02-15 2008-02-14 Wnt3a for inhibition of scarring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0702930.9A GB0702930D0 (en) 2007-02-15 2007-02-15 Medicaments and methods for inhibition of scarring

Publications (1)

Publication Number Publication Date
GB0702930D0 true GB0702930D0 (en) 2007-03-28

Family

ID=37908674

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0702930.9A Ceased GB0702930D0 (en) 2007-02-15 2007-02-15 Medicaments and methods for inhibition of scarring

Country Status (7)

Country Link
US (1) US20110212897A1 (enExample)
EP (1) EP2117581A1 (enExample)
JP (1) JP2010519192A (enExample)
AU (1) AU2008216004A1 (enExample)
CA (1) CA2678389A1 (enExample)
GB (1) GB0702930D0 (enExample)
WO (1) WO2008099174A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8725477B2 (en) 2008-04-10 2014-05-13 Schlumberger Technology Corporation Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics
WO2009126888A2 (en) 2008-04-10 2009-10-15 Services Petroliers Schlumberger Method for characterizing a geological formation traversed by a borehole
ES2341419B1 (es) * 2008-08-14 2011-05-03 Hospital Clinic I Provincial De Barcelona Wnt1 como biomarcador de daño renal.
EP2226080A1 (en) * 2009-03-05 2010-09-08 Universiteit Maastricht Antagonistic peptides for frizzled-1 and frizzled-2
US8311788B2 (en) 2009-07-01 2012-11-13 Schlumberger Technology Corporation Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261189A1 (en) * 2004-04-16 2005-11-24 Hydra Biosciences, Inc. Methods of promoting cardiac cell proliferation
CN101128212A (zh) * 2005-01-18 2008-02-20 国立大学法人京都大学 用于神经细胞再生的药物
GB0613031D0 (en) * 2006-06-30 2006-08-09 Renovo Ltd Medicaments

Also Published As

Publication number Publication date
AU2008216004A1 (en) 2008-08-21
EP2117581A1 (en) 2009-11-18
US20110212897A1 (en) 2011-09-01
WO2008099174A1 (en) 2008-08-21
CA2678389A1 (en) 2008-08-21
JP2010519192A (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
EP2026843A4 (en) THERAPEUTIC USES OF RTP801L INHIBITORS
PT2397142T (pt) Utilizações de inibidores da dpp iv
ZA201404552B (en) Benzoxepin pi3k inhibitor compound and use thereof
ZA201001051B (en) Benzylbenzene derivatives and methods of use
IL199727A0 (en) Inhibitors of mek
ZA201008957B (en) Triazolopyridine jak inhibitor compounds and methods
IL209764A0 (en) Triazolopyridine jak inhibitor compounds and methods
IL211835A0 (en) Therapeutic uses of inhibitors of rtp801
EP2200977A4 (en) F1F0-ATPASE INHIBITOR AND ASSOCIATED METHODS
GB0724231D0 (en) Methods for inhibiting scarring
IL200576A0 (en) Inhibitors of rtp801 and their uses
IL201367A0 (en) 2 - morpholin - 4 - yl - pyrimidines as pi3k inhibitors
SI2379096T1 (sl) Zaviralci TFPI in postopki uporabe
EP2242501A4 (en) THERAPEUTIC INHIBITORS OF PAI-I FUNCTION AND METHODS OF USE
IL209512A0 (en) Inhibitor of analgesic tolerance
GB0622084D0 (en) Inhibitors of HSP90
GB0702930D0 (en) Medicaments and methods for inhibition of scarring
GB0719248D0 (en) Compounds and methods for pharmaceutical use
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
GB0707348D0 (en) Medicaments and methods for inhibition of scarring
GB0810063D0 (en) Medicaments and methods for inhibition of scarring
ZA200900708B (en) Use of WNT5A for inhibiting scarring
GB0714934D0 (en) Medicaments and methods for inhibition of scarring
GB0625966D0 (en) Medicaments and methods for promoting wound contraction
IL202766A0 (en) Pharmaceutical combination of opioid and prostaglandin compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)